- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT06540833
알츠하이머병과 관련된 정신병 치료에서 ITI-1284의 효능과 안전성을 평가하기 위한 연구
알츠하이머병과 관련된 정신병 환자에서 ITI-1284의 효능, 안전성 및 내약성을 평가하기 위한 다기관, 무작위, 이중 맹검, 위약 대조, 탄력적 용량 연구
This is a multicenter, randomized, double-blind, parallel-group, placebo-controlled, flexible-dose study evaluating the efficacy, safety, and tolerability of ITI-1284 compared with placebo in the treatment of psychosis in patients with AD.
연구 개요
연구 유형
등록 (추정된)
단계
- 2 단계
연락처 및 위치
연구 연락처
- 이름: Study Contact
- 전화번호: 844-434-4210
- 이메일: Participate-In-This-Study1@its.jnj.com
연구 장소
-
-
-
Bucharest, 루마니아, 041914
- 모병
- Spitalul Clinic de Psihiatrie Prof Dr Alexandru Obregia
-
Bucharest, 루마니아, 010825
- 모병
- Spitalul Universitar de Urgenta Militar Central 'Dr. Carol Davila'
-
Bucharest, 루마니아, 040874
- 모병
- Spitalul Clinic de Psihiatrie Prof Dr Alexandru Obregia 1
-
Bucharest, 루마니아, 60222
- 완전한
- Centrul de Evaluarea si Tratament al Toxicodependentelor pentru Tineri Sf. Stelian
-
Galati, 루마니아, 800179
- 모병
- Spitalul De Psihiatrie Elisabeta Doamna Galaţi
-
Sibiu, 루마니아, 550281
- 모병
- SC Carpe Diem SRL
-
-
-
-
California
-
Anaheim, California, 미국, 92805
- 모병
- Advanced Research Center, Inc
-
Los Alamitos, California, 미국, 90720
- 완전한
- Pharmacology Research Institute
-
Newport Beach, California, 미국, 92660
- 완전한
- Wr Pri Llc
-
Orange, California, 미국, 92866
- 완전한
- ATP Clinical Research
-
Walnut Creek, California, 미국, 94596
- 모병
- Sunwise Clinical Research
-
-
Florida
-
Bonita Springs, Florida, 미국, 34134
- 모병
- Envision Trials LLC
-
Brandon, Florida, 미국, 33511
- 모병
- Clinical Research of Brandon
-
Coral Springs, Florida, 미국, 33067
- 완전한
- Healthcare Innovations Institute Inc
-
Delray Beach, Florida, 미국, 33445
- 완전한
- Brain Matters Research
-
Doral, Florida, 미국, 33178
- 모병
- Science Connections LLC
-
Homestead, Florida, 미국, 33033
- 모병
- Homestead Associates in Research Inc
-
Maitland, Florida, 미국, 32751
- 모병
- K2 Medical Research
-
Miami, Florida, 미국, 33155-4630
- 모병
- Allied Biomedical Research Institute (ABRI), Inc
-
Miami, Florida, 미국, 33135
- 모병
- Wellness Research Center
-
Miami, Florida, 미국, 33166
- 모병
- South Florida Research Phase I-IV
-
Miami, Florida, 미국, 33144
- 정지된
- Ocean Blue Medical Research Center Inc.
-
Miami, Florida, 미국, 33186
- 모병
- Sunshine Medical Solution
-
Orlando, Florida, 미국, 32803
- 완전한
- Combined Research Orlando
-
Sarasota, Florida, 미국, 34239
- 모병
- Intercoastal Medical Group
-
Tampa, Florida, 미국, 33613
- 모병
- University of South Florida
-
Tampa, Florida, 미국, 33614
- 완전한
- Psych Me Medical Research Inc
-
-
Georgia
-
Savannah, Georgia, 미국, 31405
- 모병
- CenExeli Research LLC
-
-
New Jersey
-
Toms River, New Jersey, 미국, 08755
- 모병
- Bio Behavioral Health
-
-
North Carolina
-
Charlotte, North Carolina, 미국, 28211
- 모병
- New Hope Clinical Research
-
Matthews, North Carolina, 미국, 28105
- 모병
- AMC Research, LLC
-
-
Texas
-
Cypress, Texas, 미국, 77065
- 모병
- Horizon Clinical Research Group
-
San Antonio, Texas, 미국, 78229-3900
- 완전한
- University of Texas Health Science Center at San Antonio
-
-
Washington
-
Bellevue, Washington, 미국, 98007
- 모병
- Northwest Clinical Research Center
-
-
-
-
-
Blagoevgrad, 불가리아, 2700
- 완전한
- Medical Center Sv Dimitar Blagoevgrad
-
Cherven Bryag, 불가리아, 5980
- 모병
- Ambulatory for Individual Practice for Specialized Medical Care in Psychiatry Dr. Ivo Natsov ET
-
Sofia, 불가리아, 1680
- 모병
- Medical Center Intermedica, OOD
-
Sofia, 불가리아, 1408
- 모병
- DCC 'Sv. Vrach and Sv. Sv. Kuzma and Damyan', OOD
-
Sofia, 불가리아, 1510
- 모병
- Medical Center Hera EOOD
-
Sofia, 불가리아, 1377
- 모병
- Mental Health Centre Prof. N Shipkovenski EOOD
-
Stara Zagora, 불가리아, 6003
- 모병
- UMHAT Prof. Dr. St. Kirkovich AD
-
Vratsa, 불가리아, 3000
- 완전한
- Mental Health Center - Vratsa EOOD
-
-
-
-
-
Belgrade, 세르비아, 11000
- 모병
- Clinical Center Dr Dragisa Misovic Dedinje
-
Kovin, 세르비아, 26220
- 완전한
- Special Hospital for Psychiatric Diseases Kovin
-
Kragujevac, 세르비아, 34000
- 모병
- University Clinical Center Kragujevac
-
Niš, 세르비아, 18000
- 모병
- University Clinical Center NIS
-
Novi Kneževac, 세르비아, 23330
- 정지된
- Special Hospital for Psychiatric Diseases Sveti Vracevi
-
-
-
-
-
Albacete, 스페인, 02006
- 정지된
- Hosp. Gral. de Albacete
-
Zamora, 스페인, 49021
- 모병
- Hosp. Prov. de Zamora
-
Zaragoza, 스페인, 50012
- 정지된
- Hosp. Viamed Montecanal
-
-
-
-
-
Banská Bystrica, 슬로바키아, 97404
- 완전한
- Neurologicka ambulancia MUDr.Dupejova s.r.o.
-
Bratislava, 슬로바키아, 81369
- 정지된
- Univerzitna nemocnica Bratislava
-
Košice, 슬로바키아, 04190
- 모병
- Univerzitna nemocnica L. Pasteura Kosice
-
Košice, 슬로바키아, 4001
- 모병
- Epamed sro
-
Krompachy, 슬로바키아, 05342
- 모병
- NEURES s r o
-
Vranov nad Topľou, 슬로바키아, 09301
- 모병
- Crystal Comfort s.r.o.
-
-
-
-
-
Arzignano, 이탈리아, 36071
- 모병
- Ospedale di Arzignano
-
Brescia, 이탈리아, 25123
- 모병
- Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia Presidio Spedali Civili
-
Cefalù, 이탈리아, 90015
- 모병
- Fondazione Istituto G. Giglio
-
Tricase, 이탈리아, 73039
- 모병
- Ospedale Cardinale G. Panico
-
-
-
-
-
Brno, 체코, 60200
- 모병
- Fakultni nemocnice u sv. Anny v Brne
-
Brno, 체코, 62800
- 모병
- Neuro Health Centrum s r o
-
Hradec Králové, 체코, 50002
- 모병
- NEUROHK s r o
-
Prague, 체코, 18600
- 완전한
- INEP medical s.r.o.
-
-
-
-
-
Zagreb, 크로아티아, 10000
- 모병
- University Hospital Centre Zagreb
-
Zagreb, 크로아티아, 10000
- 모병
- Polyclinic Neuron
-
Zagreb, 크로아티아, 10000
- 완전한
- University Hospital Centre Zagreb 1
-
Zagreb, 크로아티아, 10090
- 모병
- Psychiatric Clinic "VRAPCE"
-
-
-
-
-
Bydgoszcz, 폴란드, 85 080
- 완전한
- Przychodnia Srodmiescie SP. z o.o.
-
Katowice, 폴란드, 40-749
- 완전한
- Neuro Care
-
Ścinawa, 폴란드, 59-330
- 완전한
- Osrodek Badawczo Naukowo Dydaktyczny Chorob Otepiennych UM im Piastow Slaskich we Wroclawiu
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
-
Can understand the nature of the trial and protocol requirements and provide signed informed consent, if in the judgement of the Investigator is deemed competent to provide consent or if patient is deemed not competent to provide informed consent, with the patient's assent (if capable), consent may be provided by an appropriate person (eg, patient's Legally Authorized Representative [LAR]) before the initiation of any study-specific procedures in accordance with local regulations
-
Meets clinical criteria for AD based on 2011 NIA-AA criteria and either:
- Has a high likelihood for amyloid pathology consistent with AD, as confirmed by blood-based biomarker at Screening as detected by an appropriately validated test; or
- Has documented confirmation of AD by cerebrospinal fluid (CSF) biomarker or amyloid positron emission tomography (PET) brain scan
-
Meets criteria for psychosis in accordance with the International Psychogeriatric Association (IPA) provisional consensus definition at Screening and Baseline
-
Scoring ≥ 2 on any item of the BEHAVE-AD Part A. Paranoid and Delusional Ideation item and/or Part B. Hallucinations item (ie, psychosis subscale) at Screening and Baseline
-
CGI-S score ≥ 4 at Screening and Baseline
-
Mini-Mental State Examination, 2nd Edition™: Standard Version (MMSE-2®:SV) score of 6 to 24 (inclusive) at Screening with sufficient verbal ability to understand and answer questions and comply with procedures
-
Has a designated caregiver (eg, relative, housemate, close personal friend, or professional caregiver)
Exclusion Criteria:
-
Psychotic symptoms that are primarily attributable to delirium, substance abuse, or another general-medical condition (for example, hypothyroidism) or has been diagnosed with one or more of the following psychiatric conditions:
- Schizophrenia, schizoaffective disorder, or other psychotic disorder that is not related to Alzheimer's dementia
- Bipolar disorder
-
Risk for suicidal behavior during the course of their participation in the study or is considered to be an imminent danger to themselves or others, in the opinion of the investigator, and/or as assessed by C-SSRS; or the patient has had 1 or more suicide attempts within 2 years prior to Screening
-
The patient is unable or unwilling to discontinue other drugs with known psychotropic properties or any non-psychotropic drugs with known or potentially significant central nervous system effects, as reviewed by the Sponsor or designee
-
The patient is hospitalized or receiving skilled nursing care for any medical condition other than dementia
-
The patient is bedridden or has any significant medical condition that is unstable and would either:
- Place the patient at undue risk from study drug or undergoing study procedures; or
- Interfere with the interpretation of safety or efficacy evaluations performed during the course of the study
-
The patient is in hospice or end-of-life care
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 네 배로
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
위약 비교기: 위약
|
Placebo rapidly disintegrating tablet, taken once daily, sublingual administration |
|
실험적: ITI-1284
|
ITI-1284 10 mg or 20 mg rapidly disintegrating tablet, taken once daily, sublingual administration |
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
BEHAVE-AD psychosis subscale score
기간: Week 6
|
The BEHAVE-AD psychosis subscale is comprised of 7 items from the paranoid and delusional ideations domain and 5 items from the hallucinations domain. The scale is rated on a 4--point scale of severity, from 0 (not present) to 3 (present, generally with an emotional and physical component). The maximum score for the psychosis subscale is 36. |
Week 6
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
CGI-S score
기간: Week 6
|
The CGI-S is a clinician-rated scale to assess a patient's overall mental health. The scale ranges from 1 (normal, not at all ill) to 7 (among the most extremely ill patients) |
Week 6
|
공동 작업자 및 조사자
수사관
- 연구 책임자: Intra-Cellular Therapies, Inc. Clinical Trial, Intra-Cellular Therapies, Inc.
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .